Matches in Wikidata for { <http://www.wikidata.org/entity/Q37645926> ?p ?o ?g. }
- Q37645926 description "2017 թվականի փետրվարի 10-ին հրատարակված գիտական հոդված" @default.
- Q37645926 description "article científic" @default.
- Q37645926 description "article scientifique" @default.
- Q37645926 description "articolo scientifico" @default.
- Q37645926 description "artigo científico" @default.
- Q37645926 description "artículu científicu espublizáu en 2017" @default.
- Q37645926 description "bilimsel makale" @default.
- Q37645926 description "scientific article published on 10 February 2017" @default.
- Q37645926 description "vedecký článok" @default.
- Q37645926 description "vetenskaplig artikel" @default.
- Q37645926 description "videnskabelig artikel" @default.
- Q37645926 description "vědecký článek" @default.
- Q37645926 description "wetenschappelijk artikel" @default.
- Q37645926 description "wissenschaftlicher Artikel" @default.
- Q37645926 description "наукова стаття, опублікована в лютому 2017" @default.
- Q37645926 description "научни чланак" @default.
- Q37645926 description "مقالة علمية نشرت في 10 فبراير 2017" @default.
- Q37645926 name "Risk of gynecomastia and breast cancer associated with the use of 5-alpha reductase inhibitors for benign prostatic hyperplasia." @default.
- Q37645926 name "Risk of gynecomastia and breast cancer associated with the use of 5-alpha reductase inhibitors for benign prostatic hyperplasia." @default.
- Q37645926 name "Risk of gynecomastia and breast cancer associated with the use of 5-alpha reductase inhibitors for benign prostatic hyperplasia." @default.
- Q37645926 type Item @default.
- Q37645926 label "Risk of gynecomastia and breast cancer associated with the use of 5-alpha reductase inhibitors for benign prostatic hyperplasia." @default.
- Q37645926 label "Risk of gynecomastia and breast cancer associated with the use of 5-alpha reductase inhibitors for benign prostatic hyperplasia." @default.
- Q37645926 label "Risk of gynecomastia and breast cancer associated with the use of 5-alpha reductase inhibitors for benign prostatic hyperplasia." @default.
- Q37645926 prefLabel "Risk of gynecomastia and breast cancer associated with the use of 5-alpha reductase inhibitors for benign prostatic hyperplasia." @default.
- Q37645926 prefLabel "Risk of gynecomastia and breast cancer associated with the use of 5-alpha reductase inhibitors for benign prostatic hyperplasia." @default.
- Q37645926 prefLabel "Risk of gynecomastia and breast cancer associated with the use of 5-alpha reductase inhibitors for benign prostatic hyperplasia." @default.
- Q37645926 P1433 Q37645926-4B9D80AB-F74F-4613-8ABC-50CEB1F5CF44 @default.
- Q37645926 P1476 Q37645926-4E2143B0-DFDA-4F60-B256-647CEB5B7EAC @default.
- Q37645926 P2093 Q37645926-629E620E-5D7B-48E9-9882-265911BC4F80 @default.
- Q37645926 P2093 Q37645926-72277E31-E994-4E93-A0C3-9CEC01F4A927 @default.
- Q37645926 P2093 Q37645926-7EAF5F75-86A8-456C-9C29-17422A9AAEE0 @default.
- Q37645926 P2093 Q37645926-9E4B9798-557C-49A6-A48D-18481C1796E2 @default.
- Q37645926 P275 Q37645926-58a45f23-7e55-436d-bf80-bc3632fba3f2 @default.
- Q37645926 P2860 Q37645926-24D8207F-8BA9-4101-B851-FE8D0E4632A3 @default.
- Q37645926 P2860 Q37645926-3473D5F2-E4F2-4E9B-9404-B0D084121F48 @default.
- Q37645926 P2860 Q37645926-4DE87894-2D2B-4365-9B79-356FFA3927F2 @default.
- Q37645926 P2860 Q37645926-4E959AA1-0E6F-4DC1-89E8-DD2CFE1A56AD @default.
- Q37645926 P2860 Q37645926-5A6D2A05-5715-46CF-A057-17F3B4C7DB60 @default.
- Q37645926 P2860 Q37645926-67288059-4B85-49BD-9E70-6AB2141858FE @default.
- Q37645926 P2860 Q37645926-6A06BB97-373D-448A-B55D-CE6EA4D3F647 @default.
- Q37645926 P2860 Q37645926-6EA8FF86-FFBE-4A78-A9D2-E6609A7174AC @default.
- Q37645926 P2860 Q37645926-6F1BC94C-C19F-43F6-BA96-5F7E89048F21 @default.
- Q37645926 P2860 Q37645926-79805315-2139-4C65-9D66-A3B1CCDAC5C5 @default.
- Q37645926 P2860 Q37645926-7A3B9C0A-03BC-4DED-8184-11D937CD8389 @default.
- Q37645926 P2860 Q37645926-86ECB01D-FF0E-49FB-880F-66E49EA9707B @default.
- Q37645926 P2860 Q37645926-8752A6DA-2BC5-43FA-8599-978DA7AA357D @default.
- Q37645926 P2860 Q37645926-9835DEF7-F76E-4AFD-AE45-726E60C095A9 @default.
- Q37645926 P2860 Q37645926-9D3594B8-1BD7-4392-851C-ABF2FBB30795 @default.
- Q37645926 P2860 Q37645926-9EB077FC-D1B5-4C79-BF3E-47EC07081C24 @default.
- Q37645926 P2860 Q37645926-B1F3670D-E676-47C8-B8E7-80B4E20D038B @default.
- Q37645926 P2860 Q37645926-E475BD4D-7261-4878-AA7A-E6319583C056 @default.
- Q37645926 P2860 Q37645926-FAC72C26-6803-4497-9438-43331AA6863C @default.
- Q37645926 P304 Q37645926-F0BA1805-F224-4068-B17A-6F5F0A108DF0 @default.
- Q37645926 P31 Q37645926-A4FCD59D-69E3-4533-876F-A0392D7662A1 @default.
- Q37645926 P356 Q37645926-E1C28FF0-0405-499F-9B8D-23AE7EE69822 @default.
- Q37645926 P407 Q37645926-8D32F4C2-3178-4A98-A00E-190F25C6F457 @default.
- Q37645926 P478 Q37645926-B3BA9AC8-6EC0-4D79-A50C-7F74E9CEDE1D @default.
- Q37645926 P50 Q37645926-82C649CB-C2E2-48DE-9DD3-FC9928784D3C @default.
- Q37645926 P577 Q37645926-1BBB34A2-B8A0-445A-ABEC-092ABC8468CC @default.
- Q37645926 P6216 Q37645926-95f456b9-b0c8-436b-8fb1-c424e9e22724 @default.
- Q37645926 P698 Q37645926-E24EE5EA-D7ED-4626-B4A8-75B0B1D171F1 @default.
- Q37645926 P932 Q37645926-AE791D98-DCCD-4AAC-BC8C-1B8FE2A9A8EF @default.
- Q37645926 P356 CLEP.S124674 @default.
- Q37645926 P698 28228662 @default.
- Q37645926 P1433 Q5133758 @default.
- Q37645926 P1476 "Risk of gynecomastia and breast cancer associated with the use of 5-alpha reductase inhibitors for benign prostatic hyperplasia" @default.
- Q37645926 P2093 "Hozefa A Divan" @default.
- Q37645926 P2093 "J Curtis Nickel" @default.
- Q37645926 P2093 "Katrina Wilcox Hagberg" @default.
- Q37645926 P2093 "Shona C Fang" @default.
- Q37645926 P275 Q18810331 @default.
- Q37645926 P2860 Q28245725 @default.
- Q37645926 P2860 Q28272451 @default.
- Q37645926 P2860 Q28645951 @default.
- Q37645926 P2860 Q30010961 @default.
- Q37645926 P2860 Q33961645 @default.
- Q37645926 P2860 Q34534815 @default.
- Q37645926 P2860 Q35967935 @default.
- Q37645926 P2860 Q38991761 @default.
- Q37645926 P2860 Q42552947 @default.
- Q37645926 P2860 Q42675109 @default.
- Q37645926 P2860 Q45778181 @default.
- Q37645926 P2860 Q47402898 @default.
- Q37645926 P2860 Q47921352 @default.
- Q37645926 P2860 Q51406334 @default.
- Q37645926 P2860 Q53236407 @default.
- Q37645926 P2860 Q58674834 @default.
- Q37645926 P2860 Q73512906 @default.
- Q37645926 P2860 Q87445981 @default.
- Q37645926 P2860 Q87611500 @default.
- Q37645926 P304 "83-91" @default.
- Q37645926 P31 Q13442814 @default.
- Q37645926 P356 "10.2147/CLEP.S124674" @default.
- Q37645926 P407 Q1860 @default.
- Q37645926 P478 "9" @default.
- Q37645926 P50 Q42946335 @default.
- Q37645926 P577 "2017-02-10T00:00:00Z" @default.
- Q37645926 P6216 Q50423863 @default.
- Q37645926 P698 "28228662" @default.